title: Effect of serotonergic system on AVP secretion induced by physical exercise.
abstract: The present study was undertaken in order to establish the possible involvement of serotonergic receptors in the control of physical exercise-stimulated vasopressin secretion. Twenty-one healthy men (divided in three groups of seven) underwent bicycle-ergometer tests until exhaustion: exercise control test (n=21), exercise plus ondansetron, selective 5-HT3 antagonist (n=7), exercise plus buspirone, selective 5-HT1A receptor agonist (n=7), exercise plus sumatriptan, selective 5-HT1D receptor agonist (n=7). AVP levels, physiological and biochemical variables were measured and compared during tests. Results showed that exercise-induced AVP rise did not change after the administration of buspirone and sumatriptan. In contrast, the administration of ondansetron significantly reduced physical exercise-induced AVP rise. Mean peak levels during physical exercise were 4.9 times higher than basal values in the control test and 2.6 times higher than basal values in the ondansetron plus exercise test. These data demonstrate that 5-HT3 serotonergic receptors at least partially mediate the AVP response to physical exercise. On the other hand, 5-HT1A and 5-HT1D serotonergic receptors do not appear to be involved in the control of AVP secretion during exercise.
authors.affiliation: Department of Internal Medicine and Biochemical Sciences, University of Parma, Parma, Italy. vittorio.coiro@unipr.it
authors.forename: V
authors.initials: V
authors.lastname: Coiro
authors.forename: M L
authors.initials: ML
authors.lastname: Maffei
authors.forename: E
authors.initials: E
authors.lastname: Volta
authors.forename: S
authors.initials: S
authors.lastname: Cataldo
authors.forename: R
authors.initials: R
authors.lastname: Minelli
authors.forename: P
authors.initials: P
authors.lastname: Vacca
authors.forename: R
authors.initials: R
authors.lastname: Volpi
authors.forename: P
authors.initials: P
authors.lastname: Chiodera
mesh_terms: D000328:Adult; D001127:Arginine Vasopressin / Q000097:blood*; D001786:Blood Glucose / Q000378:metabolism; D002065:Buspirone / Q000494:pharmacology; D015444:Exercise / Q000502:physiology*; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008297:Male; D017294:Ondansetron / Q000494:pharmacology; D009994:Osmolar Concentration; D012701:Serotonin / Q000502:physiology*; D017366:Serotonin Receptor Agonists / Q000494:pharmacology*; D018170:Sumatriptan / Q000494:pharmacology; D055815:Young Adult
chemical_list: D001786:Blood Glucose; D017366:Serotonin Receptor Agonists; D001127:Arginine Vasopressin; D012701:Serotonin; D017294:Ondansetron; D018170:Sumatriptan; D002065:Buspirone